[ARWR] YoY Quarter Result on 31-Dec-2016 [#Q1]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
06-Feb-2017
Financial Year
2017
Quarter
31-Dec-2016 [#Q1]
Profit Trend
QoQ- 45.61%
YoY- 37.26%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 29,455 34,658 3,510 4,365 44 171 44 195.62%
PBT -2,674 12,037 -13,199 -12,086 -19,264 -22,575 -10,686 -20.60%
Tax 1 -0 -614 -1,509 -77 -2,593 -57,420 -
NP -2,674 12,037 -13,199 -12,086 -19,264 -22,575 -10,628 -20.53%
Tax Rate - 0.00% - - - - - -
Total Cost 32,128 22,621 16,709 16,452 19,308 22,746 10,672 20.15%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -9.08 34.73 -376.06 -276.86 -44,032.95 -13,221.25 -24,293.28 -73.14%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -0.03 0.13 -0.18 -0.17 -0.32 -0.41 -0.28 -31.07%
EPS Diluted -0.03 0.13 -0.18 -0.17 -0.32 -0.41 -0.28 -31.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.